Valuation: CONMED Corporation

Market Cap 1.53B 1.38B 1.26B 1.15B 2.16B 144B 2.23B 15.16B 6.05B 76.99B 5.76B 5.64B 243B P/E 2026 *
13.6x
P/E 2027 * 11.4x
Enterprise Value 2.28B 2.04B 1.87B 1.7B 3.21B 214B 3.31B 22.5B 8.97B 114B 8.55B 8.36B 361B EV / Sales 2026 *
1.67x
EV / Sales 2027 * 1.53x
Free-Float
95.01%
Yield 2026 *
-
Yield 2027 * -
1 day-2.52%
1 week+16.28%
Current month+16.28%
1 month+15.78%
3 months+3.48%
6 months+38.00%
Current year+26.85%
1 week 44.76
Extreme 44.76
54.8
1 month 43.5
Extreme 43.5
54.8
Current year 31.44
Extreme 31.44
54.8
1 year 31.44
Extreme 31.44
54.8
3 years 31.44
Extreme 31.44
117.27
5 years 31.44
Extreme 31.44
158.46
10 years 31.44
Extreme 31.44
159.11
Manager TitleAgeSince
Chief Executive Officer 60 31/12/2024
Director of Finance/CFO 53 14/07/2026
Chief Tech/Sci/R&D Officer 50 31/12/2024
Director TitleAgeSince
Director/Board Member 74 22/07/2014
Director/Board Member 60 31/12/2024
Director/Board Member 72 30/06/2015
Date Insider Type Main position Quantity % Market Cap. Importance
08/09/26 Exercice

Director

1,000 0.0033%
15/07/26 Other

Chief Financial Officer

0 0%
15/07/26 Free

Chief Financial Officer

92,465 0.3071%
Change 5-day change 1-year change 3-year change Capi.($)
-2.52%+16.28%+16.49%-49.77% 1.53B
-3.23%+3.51%-12.02%+15.72% 190B
-2.90%+5.45%+13.04%+38.65% 125B
-2.75%+11.65%-7.90%+17.71% 124B
+0.96%+5.15%-38.02%+12.24% 99.31B
-1.80%+0.82%-7.41%+69.42% 63.65B
-0.78%+7.07%+19.44%-18.22% 57.71B
+0.79%+22.65%-5.28%+59.81% 53.26B
-6.98%-14.56%-12.60%+42.69% 47.03B
-2.36%+3.72%+3.27%-8.07% 36.15B
Average -2.16%+6.37%-3.10%+18.02% 79.77B
Weighted average by Cap. -2.20%+5.73%-6.89%+24.34%

Financials

2026 *2027 *
Net sales 1.36B 1.22B 1.12B 1.02B 1.92B 128B 1.98B 13.46B 5.37B 68.35B 5.11B 5.01B 216B 1.43B 1.28B 1.17B 1.07B 2.01B 134B 2.07B 14.09B 5.62B 71.53B 5.35B 5.24B 226B
Net income 114M 103M 93.78M 85.61M 161M 10.75B 166M 1.13B 451M 5.74B 429M 420M 18.12B 137M 123M 112M 102M 193M 12.86B 199M 1.35B 539M 6.86B 513M 502M 21.66B
Net Debt 742M 666M 609M 556M 1.05B 69.79B 1.08B 7.34B 2.92B 37.24B 2.79B 2.73B 118B 646M 579M 529M 483M 910M 60.69B 939M 6.38B 2.54B 32.38B 2.42B 2.37B 102B
Projected Income Statement - Annual - CONMED Corporation
Logo CONMED Corporation
CONMED Corporation is a medical technology company which provides devices and equipment for surgical procedures. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product line consists of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Employees
3,900
Date Price Change Volume
06/11/26 US$51.50 -2.52% 331,564
05/11/26 US$52.83 -1.55% 406,922
04/11/26 US$53.66 +13.61% 592,354
03/11/26 US$47.23 +1.37% 510,102
02/11/26 US$46.59 +5.19% 444,226
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - CONMED Corporation
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
51.50USD
Average target price
46.83USD
Spread / Average Target
-9.06%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CONMED Corporation
  1. Stock Market
  2. Stocks
  3. CNMD Stock